Related Experiment Video
Updated: May 7, 2026

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Comparing disease activity indices in ulcerative colitis
A J Walsh1, A Ghosh2, A O Brain3
1Currently at Department of Gastroenterology, St Vincent's Hospital, Sydney, Australia.
Inter-observer variation in ulcerative colitis (UC) disease activity indices impacts clinical trials. The Seo index showed the best agreement, but all indices can affect patient recruitment and outcomes.
Area of Science:
- Gastroenterology
- Clinical Trial Methodology
- Inflammatory Bowel Disease Research
Background:
- Limited comparisons exist for ulcerative colitis (UC) disease activity indices.
- Understanding inter-observer variation is crucial for clinical trial design and interpretation.
Purpose of the Study:
- To evaluate and compare three UC disease activity indices: Simple Clinical Colitis Activity (SCCAI), Mayo Clinic, and Seo.
- To assess the impact of inter-observer variation on clinical trial recruitment and outcomes.
- To determine the clinical relevance of these indices.
Main Methods:
- Prospective evaluation of 100 UC patients by four specialists.
- Videosigmoidoscopy scored by each specialist.
- Comparison of SCCAI, Mayo Clinic, and Seo indices using Kappa statistics for inter-observer agreement and clinical relevance assessment.
Main Results:
- Good to very good inter-observer agreement was observed for SCCAI (κ=0.75), Mayo Clinic (κ=0.72), and Seo (κ=0.89) indices.
- Endoscopic scoring within the Mayo Clinic index exhibited the highest variation (κ=0.38).
- Inter-observer variation could exclude up to 20% of patients from trial recruitment or remission criteria.
Conclusions:
- Inter-observer variation in UC activity indices significantly affects clinical trial recruitment and outcome measures.
- Endoscopic scoring is the most variable component among the evaluated indices.
- The Seo index demonstrated the highest inter-observer agreement, suggesting potential advantages in consistency.
Related Concept Videos
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Introduction
Drugs for Treatment of Ulcerative Colitis in IBD

